Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
The purpose of this study is to determine the prevalence of Fabry mutations in patients with
 left ventricular hypertrophy (moderate to severe), as measured by echocardiography.This study
 is a screening study
Inclusion Criteria:

 -  All patients over 18 years undergoing a routine echocardiography in the participating
 hospitals

 -  Both genders will be considered.

 -  Patients can be included if on 2D echocardiography the maximal septal wall thickness >
 13 mm and/or the posterior wall thickness > 13 mm. The limit for inclusion is kept
 relatively low to detect early forms of Fabry cardiomyopathy.